Even though Cyclosporin A has been proved to be highly nephrotoxic when used alone in large doses, combining it with other drugs brought impressive improvements in immunosuppressive therapy (10) .
After introduction of this drug for liver transplantation, the oneyear survival doubled and, in succeeding years, the advantages became even greater. In 1981, Cosimi et al. (11) of Boston added another weapon to the therapeutic armamentarium, namely a modernday ALG, which is a murine monoclonal antibody (OKT3) directed against mature lymphocytes.
In the early years of clinical application, the kidney was the only whole organ transplanted. In 1963, the first attempts were made to transplant the liver (12) . Four of the first five patients survived the operation, but the maximum survival was only 23 days.
Nevertheless, the principles of orthotopic liver transplantation were nearly completely delineated. The first prolonged human survivals were achieved in 1967 under treatment with azathioprine, prednisone, and ALG (13) . What has happened since has made liver transplantation a service that has changed the practice of hepa to logy (14) . It is also highly promising that short courses of FK 506 may have long-lasting effects on graft rejection. Such long-lasting STARZL immunosuppression in dogs after brief time treatment has been reported in the past only with antilymphocyte serum (ALS). In dogs treated on days 4, 5, and 6 after grafting of allogeneic kidneysi.e. at a time when, without treatment, histological and biochemical signs of rejection can be seen -acceptance of grafts was observed in 50% of the animals for prolonged periods of time. Some of the dogs have had a functioning kidney graft for over six months (17) .
The same has been achieved with livers (17).
The results of toxicity studies on FK 506 can be summarized as follows. There is toxicity in dogs: intussusception of intestines and systemic arteritis have been described. However, even without FK 506 treatment, arteritis occurs in dogs after transplantation (17) . In rats and baboons, FK 506 seems to have only minor toxic effects (17) . Last November 1, an infant was treated at our clinic who had lost all of her midgut but who had survived with the shortgut syndrome for 2.5 years on parenteral hyperalimentation. She then developed irreversible liver disease. We decided to attempt the same transplantation of multiple viscera which had been worked out in animals in 1960. A donor was available 407 miles from Pittsburgh.
Concentration of FK
We treated the donor with OKT3. Later, Shaffer et al. (27) reported that donor pretreatment with ALS in rats completely abolished the undirectional graft versus host reaction (GVH) of their experimental model.
Our patient never had evidence of GVH disease. The intake of nutrients through the intestinal graft improved over time, so that hyperalimentation could be reduced and ultimately almost completely stopped (28) . Gastrointestinal x-ray series showed a normal transit time. Biopsies of intestines were normal. Three months after treatment, however, the liver became the site of lymphomas associated with an Epstein Barr virus (EBV) infection (29) . These lymphoproliferative tumors of the liver had both monoclonal and polyclonal components and were of recipient origin. Cyclosporin A was discontinued. The cyclosporine levels in circulation decreased, and the liver lesions resolved with calcification of the lesional margins.
Cyclosporin A was then reinstituted, and the lesions started to grow again, compressing the biliary ducts. We could decompress partially the duct system, but just as we considered retransplantation of the liver, the child died of bacterial sepsis. Even though the transplantation eventually was thwarted by the destructive liver lesions, and the patient was lost, the parents of the child may find some consolation in the memory that everything possible was attempted. The surgical and pediatric teams were encouraged by the fact that the transplanted intestines functioned impressively in the child for many months.
Of this child, and other patients who have been the pioneers of transplantation technology in the last 30 years, it can be said that: "Diseases desperate grown by desperate appliance are reliev'd or not at all" (Claudius, in "Hamlet").
